APTICOR Trademark

Trademark Overview

On Wednesday, January 12, 2000, a trademark application was filed for APTICOR with the United States Patent and Trademark Office. The USPTO has given the APTICOR trademark a serial number of 75894437. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, February 23, 2001. This trademark is owned by Moore Products Co.. The APTICOR trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Consultation and implementation assistance services for biopharmaceutical, pharmaceutical and specialty chemical manufacturers
apticor

General Information

Serial Number75894437
Word MarkAPTICOR
Filing DateWednesday, January 12, 2000
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, February 23, 2001
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesConsultation and implementation assistance services for biopharmaceutical, pharmaceutical and specialty chemical manufacturers

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 20, 2000
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMoore Products Co.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSpring House, PA 19477

Trademark Events

Event DateEvent Description
Friday, February 23, 2001ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 13, 2000NON-FINAL ACTION MAILED
Thursday, July 6, 2000ASSIGNED TO EXAMINER

Related Keywords

apticor specialty chemical manufacturers pharmaceutical biopharmaceutical implementation assistance services consultation